• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃排空与恶心主观症状:5-羟色胺-3拮抗剂昂丹司琼对胃潴留综合征患者胃排空无影响

Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome.

作者信息

Nielsen O H, Hvid-Jacobsen K, Lund P, Langholz E

机构信息

Department of Medical Gastroenterology C, Herlev Hospital, University of Copenhagen, Denmark.

出版信息

Digestion. 1990;46(2):89-96. doi: 10.1159/000200337.

DOI:10.1159/000200337
PMID:2147664
Abstract

Thirty-seven consecutive patients referred to a regional gastroenterology outpatient clinic with complaints of persistent nausea had a double isotopic scintigraphic evaluation of solid and liquid gastric emptying. Gastric emptying of both forms followed an exponential model. Marked day to day variation of gastric emptying was noted with a coefficient of variation of approximately 0.20 for both phases. Only 9 of 37 patients had delayed gastric emptying rate of the solid component (greater than 180 min) and no correlation between gastric stasis syndrome and nausea was established. Among these patients the median time for the stomach to empty 50% of the solid component was 261 min and 50% of the liquid component was 66 min. Treatment of these 9 patients shown to have gastric stasis syndrome and further 3 patients with diabetic gastroparesis with ondansetron, a highly selective antagonist of 5-hydroxytryptamine-3-receptors, resulted in a gastric emptying rate which was not statistically faster than after placebo (p = 0.11).

摘要

37名因持续性恶心而被转诊至某地区胃肠病门诊的连续患者接受了固体和液体胃排空的双同位素闪烁扫描评估。两种形式的胃排空均遵循指数模型。胃排空存在明显的每日变化,两个阶段的变异系数约为0.20。37名患者中只有9名固体成分胃排空延迟(超过180分钟),且未确立胃潴留综合征与恶心之间的相关性。在这些患者中,胃排空50%固体成分的中位时间为261分钟,排空50%液体成分的中位时间为66分钟。对这9名被证明患有胃潴留综合征的患者以及另外3名糖尿病性胃轻瘫患者使用5-羟色胺-3-受体的高度选择性拮抗剂昂丹司琼进行治疗,结果胃排空率在统计学上并不比使用安慰剂后更快(p = 0.11)。

相似文献

1
Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome.胃排空与恶心主观症状:5-羟色胺-3拮抗剂昂丹司琼对胃潴留综合征患者胃排空无影响
Digestion. 1990;46(2):89-96. doi: 10.1159/000200337.
2
Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.贾第虫感染后肠易激综合征和功能性消化不良中内脏敏感性增加。5-羟色胺3受体拮抗剂昂丹司琼的作用。
Neurogastroenterol Motil. 2007 Dec;19(12):977-82. doi: 10.1111/j.1365-2982.2007.00988.x. Epub 2007 Aug 17.
3
Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome.昂丹司琼对类癌综合征胃肠道症状的影响。
Eur J Cancer. 1998 Jul;34(8):1293-4. doi: 10.1016/s0959-8049(98)00009-4.
4
Effect of the 5-HT3 receptor antagonist, ondansetron, on gastric size in dyspeptic patients with impaired gastric accommodation.5-羟色胺3(5-HT3)受体拮抗剂昂丹司琼对胃容纳功能受损的消化不良患者胃大小的影响。
Dig Liver Dis. 2008 Mar;40(3):188-93. doi: 10.1016/j.dld.2007.11.013. Epub 2008 Jan 31.
5
The effect of ondansetron on gastric emptying in the conscious rat.
Eur J Pharmacol. 1990 Nov 27;191(2):235-8. doi: 10.1016/0014-2999(90)94154-p.
6
Solid gastric emptying mediated by the serotonin (5-HT)3 receptor in mice is a simple marker to predict emesis.在小鼠中,由血清素(5-HT)3 受体介导的固体胃排空是预测呕吐的简单标志物。
J Toxicol Sci. 2011 Jan;36(1):23-9. doi: 10.2131/jts.36.23.
7
Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?
Aliment Pharmacol Ther. 2002 Jan;16(1):119-27. doi: 10.1046/j.1365-2036.2002.01152.x.
8
The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.新型5-羟色胺3受体拮抗剂GR38032F对豚鼠胃排空的影响。
Br J Pharmacol. 1987 Jun;91(2):263-4. doi: 10.1111/j.1476-5381.1987.tb10280.x.
9
Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.雷莫瑞林可减少糖尿病性胃轻瘫成人的呕吐频率和严重程度,并加速胃排空。
Gastroenterology. 2016 Jul;151(1):87-96.e6. doi: 10.1053/j.gastro.2016.03.038. Epub 2016 Apr 4.
10
Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.磁共振成像评估糖尿病胃轻瘫患者的胃排空和动力:西沙必利的作用
Am J Gastroenterol. 1999 Oct;94(10):2866-73. doi: 10.1111/j.1572-0241.1999.01392.x.

引用本文的文献

1
Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.用于治疗胃轻瘫症状的格拉司琼透皮系统:一项处方登记研究。
J Neurogastroenterol Motil. 2016 Oct 30;22(4):650-655. doi: 10.5056/jnm15203.
2
Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.格拉司琼透皮贴剂改善胃轻瘫患者的难治性恶心和呕吐。
Dig Dis Sci. 2014 Jun;59(6):1231-4. doi: 10.1007/s10620-014-3097-3. Epub 2014 Mar 11.
3
Recent advances in the pathophysiology and treatment of gastroparesis.
胃轻瘫的病理生理学和治疗的最新进展。
J Neurogastroenterol Motil. 2013 Jan;19(1):18-24. doi: 10.5056/jnm.2013.19.1.18. Epub 2013 Jan 8.
4
A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.静脉注射帕洛诺司琼预防成人化疗引起的恶心和呕吐的系统评价和荟萃分析。
Oncologist. 2011;16(2):207-16. doi: 10.1634/theoncologist.2010-0198. Epub 2011 Jan 31.
5
Gastroparesis: current diagnostic challenges and management considerations.胃轻瘫:当前的诊断挑战与管理考量
World J Gastroenterol. 2009 Jan 7;15(1):25-37. doi: 10.3748/wjg.15.25.
6
New developments in the treatment of functional dyspepsia.功能性消化不良治疗的新进展
Drugs. 2003;63(9):869-92. doi: 10.2165/00003495-200363090-00003.
7
Unexplained Nausea and Vomiting.不明原因的恶心和呕吐。
Curr Treat Options Gastroenterol. 2000 Aug;3(4):303-314. doi: 10.1007/s11938-000-0044-5.
8
Receptors of the enteric nervous system: potential targets for drug therapy.肠神经系统的受体:药物治疗的潜在靶点。
Gut. 2000 Dec;47 Suppl 4(Suppl 4):iv20-2; discussion iv26. doi: 10.1136/gut.47.suppl_4.iv20.
9
Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.昂丹司琼。其药理学综述及新应用中的初步临床研究结果。
Drugs. 1996 Nov;52(5):773-94. doi: 10.2165/00003495-199652050-00010.